These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3908176)

  • 1. Spironolactone treatment in scleroderma--a double-blind therapy study.
    Altmeyer P; Goerz G; Hammer H; Holzmann H; Krieg T; Luderschmidt C; Meigel WN; Mensing H
    Dermatologica; 1985; 171(5):374-5. PubMed ID: 3908176
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of scleroderma.
    Barnett AJ
    Med J Aust; 1977 Jul; 2(3):105-6. PubMed ID: 331045
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of generalized scleroderma with factor XIII. Study of 25 cases].
    Guillevin L; Chouvet B; Mery C; Thivolet J; Godeau P; Delbarre F
    Rev Med Interne; 1982; 3(3):273-7. PubMed ID: 6758093
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemolytic anemia during cyclofenil treatment of scleroderma.
    Wollheim FA; Ljunggren HO; Blom-Bülow B
    Acta Med Scand; 1981; 210(5):429-30. PubMed ID: 7039243
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immediate results of long-term treatment of systemic scleroderma with leukeran].
    Olszewska Z
    Reumatologia; 1978; 16(2):259-66. PubMed ID: 358343
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled trial of antihypertensive therapy in systemic sclerosis (scleroderma).
    Fries JF; Wasner C; Brown J; Feigenbaum P
    Ann Rheum Dis; 1984 Jun; 43(3):407-10. PubMed ID: 6378105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiclinic study of DMSO for systemic sclerosis.
    Scherbel AL
    Arthritis Rheum; 1985 Dec; 28(12):1437-8. PubMed ID: 3910051
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind comparison of spironolactone and hydrochlorothiazide in hypertensive patients treated with metoprolol.
    Lavenius B; Hansson L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jun; 20(6):291-5. PubMed ID: 7049966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of long-term use of dimethyl sulfoxide in the complex treatment of patients with systemic scleroderma].
    Murav'ev IuV; Aliab'eva AP; Sigidin IaA; Guseva NG; Balabanova RM
    Ter Arkh; 1985; 57(8):125-7. PubMed ID: 3906994
    [No Abstract]   [Full Text] [Related]  

  • 10. Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin.
    Beckett VL; Conn DL; Fuster V; Osmundson PJ; Strong CG; Chao EY; Chesebro JH; O'Fallon WM
    Arthritis Rheum; 1984 Oct; 27(10):1137-43. PubMed ID: 6386002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of prazosin in the treatment of Raynaud's phenomenon in scleroderma.
    Surwit RS; Gilgor RS; Allen LM; Duvic M
    Arch Dermatol; 1984 Mar; 120(3):329-31. PubMed ID: 6367665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.
    Furst DE; Clements PJ; Hillis S; Lachenbruch PA; Miller BL; Sterz MG; Paulus HE
    Arthritis Rheum; 1989 May; 32(5):584-93. PubMed ID: 2655606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclofenil treatment of scleroderma--a controlled study.
    Gibson T; Grahame R
    Br J Rheumatol; 1983 Nov; 22(4):218-23. PubMed ID: 6360282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection of the optimal dose of spironolactone for the treatment of benign essential hypertension].
    Rhomberg F
    Schweiz Med Wochenschr; 1977 Sep; 107(35):1228-32. PubMed ID: 335498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral spironolactone: an effective treatment for acne vulgaris in women.
    Muhlemann MF; Carter GD; Cream JJ; Wise P
    Br J Dermatol; 1986 Aug; 115(2):227-32. PubMed ID: 2943311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine therapy in scleroderma. Preliminary results.
    Frayha RA
    Dermatologica; 1979; 159(1):78-81. PubMed ID: 478046
    [No Abstract]   [Full Text] [Related]  

  • 17. Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial.
    Ortonne JP; Torzuoli C; Dujardin P; Fraitag B
    Br J Dermatol; 1989 Feb; 120(2):261-6. PubMed ID: 2647122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of systemic scleroderma with ketanserin. Randomized, double-blind 6-months study of 27 cases].
    Cadranel J; Blétry O; Guillevin L; Lacombe C; Fraitag B; Duloroy J; Mouthon JM; Godeau P
    Ann Med Interne (Paris); 1986; 137(3):260-3. PubMed ID: 3532900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight dextran in systemic sclerosis and Raynaud's phenomenon.
    Dodman B; Rowell NR
    Acta Derm Venereol; 1982; 62(5):440-2. PubMed ID: 6183899
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapy of traumatic brain edema with spironolactone (author's transl)].
    Oberbauer R; Heppner F; Auer L
    Wien Med Wochenschr; 1979 Mar; 129(5):140-3. PubMed ID: 373262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.